Powering Success From Discovery To Market: Your End-To-End Solutions Partner For Therapeutic Peptide Development

Therapeutic peptide development requires precise, reliable analysis from raw material identification through purification and quality control. Agilent provides integrated workflows for evaluating peptide purity, impurity profiles, amino acid composition, sequence integrity, stability, residual solvents, elemental impurities, and host cell proteins. Advanced LC, MS, GC, spectroscopy, automation, columns, and software help laboratories detect trace-level impurities, characterize complex molecules, streamline routine testing, and maintain data integrity. Preparative-scale purification solutions further support high-purity recovery as programs advance toward commercialization. Backed by laboratory management services, technical support, and flexible financing options, these solutions can help teams improve efficiency and confidently address evolving analytical and regulatory demands.

Discover the full range of capabilities available across the therapeutic peptide development pathway.